[1]
M. . Ružić, M. Fabri, T. Preveden, K. Bačulov, M. Pete, and A. J. Stojšin, “Autoimmune manifestation of hepatitis C virus infection as a risk for late virological relapse after pegylated interferon and ribavirin therapy”, Vojnosanit Pregl, vol. 75, no. 12, Jan. 2021, doi: 10.2298/VSP161026015R.